2023 to be highly lucrative for drug developers across therapeutic areas: Report
Citeline shares insights on a longer-term outlook at some key late-stage drugs projected to hit the market in 2023
Source: biospectrumindia.com
Page 24 - Gamida Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gamida Cell Today - Breaking & Trending Today
Gamida Cell: Omidubicel Follow Up Data Shows 63% Overall Survival At Three Years
(RTTNews) - Gamida Cell Ltd. (GMDA) reported long term follow-up data and health-related quality of life scores of patients treated with omidubice...
Source: businessinsider.com
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares - Gamida Cell (NASDAQ:GMDA) - Press Release
Gamida Cell Ltd. GMDA, the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other se
Source: wiredprnews.com
Gamida Cell Presents Data Demonstrating the Impact of Transplantation with Omidubicel for Patients with Hematologic Malignancies at 2022 Cord Blood Connect Meeting
12.09.2022 - Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the presentation of data supporting the potential of omidubicel ... Seite 1
Source: wallstreet-online.de
GRO Biosciences Announces Addition of Nicole Paulk, PhD, to Scientific Advisory Board
- Nicole Paulk, an expert in gene therapy, joins GRObio’s Scientific Advisory Board (SAB) as It Advances its ProGly™ Immunomodulation Chemistries into Gene Therapy -BOSTON--(BUSINESS WIRE)--GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphab...
Source: pharmiweb.com